← Back to catalogue
Fetal monitor
EUDAMEDFDA 510(k)Class IIa (EU MDR)
Ref FM20510(k) K100885Ref Biocare FM-1
Identity
- Device Name
- Fetal monitor EUDAMED
- Model / Reference
- FM20 EUDAMEDBiocare FM-1 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 08800012335020 EUDAMED08800012330018 EUDAMED
- Basic UDI-DI
- B-08800012335020 EUDAMEDB-08800012330018 EUDAMED
- 510(k) Number
- K100885 FDA 510(k)
- FDA Product Code
- HGM FDA 510(k)
- EMDN Code
- Z12080101 FOETAL MONITORS EUDAMED
Classification
- Device Class
- Class IIa EUDAMEDClass II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 884.2740 FDA 510(k)
- Regulation Number
- 884.2740 FDA 510(k)
- Market of Registration
- Spain EUDAMEDGermany EUDAMED
- Advisory Committee
- Obstetrics/Gynecology FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
Yes
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Fetal monitor by Bistos Co., Ltd. — Class IIa — FDA_510K, MDD — listed in EUDAMED, FDA 510(k) — regulatory data on deviCERTS
Authorization Coverage (2 countries)
Regulatory Authorizations
United States Active
FDA_510K
European Union Active
CE/MDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K100885 | Class IIa | Active |
| EUDAMED | European Union | CE/MDD | B-08800012335020 | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bistos Co., Ltd.
- EUDAMED SRN
- KR-MF-000035951
- Authorised Representative
- Obelis s.a. BE-AR-000000106
Sources (3)
- EUDAMED 5a6f43b1-aeed-431f-ab5f-e94ffd5c5ae2 61 fields · synced Jul 28, 2026
- FDA 510(k) K100885 24 fields · synced May 18, 2026
- EUDAMED 1545c767-3ae6-4ac6-a3a5-5440ed196a73 61 fields · synced Jul 9, 2026